MOUNT PLEASANT, S.C.--(BUSINESS WIRE)--Revolutions Medical Corporation (OTCBB: RMCP - News) has commenced an important step in securing European protection for the most important claims associated with the MRI patents. This step follows the previous United States PCT application filings in June 2007. “The US and European Countries make up nearly 70% of the MRI market. Securing these two markets is key for protecting our patent rights on future products that we expect to roll out in the next 12 months for our proprietary Color and 3D MRI software,” states Ron Wheet, CEO Revolutions Medical.
